WCMNY
EXAS

Westchester Capital Management (New York)’s Exact Sciences EXAS Stock Holding History

Westchester Capital Management (New York)’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-751,561
Closed -$76.3M – 320
2025
Q4 		$76.3M Buy
+751,561
New +$60.4M 3.21% 8

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Westchester Capital Management (New York)'s EXAS Position: Q1 2026 in Review

Westchester Capital Management (New York) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 751,561 shares — an estimated $76.3M sold.

Westchester Capital Management (New York) first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $76.3M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Westchester Capital Management (New York) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 751,561 Exact Sciences shares in Q1 2026, an estimated $76.3M.
  • Westchester Capital Management (New York) first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s Exact Sciences position peaked at $76.3M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2026, filed 15 May 2026.